EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer

Kojiro Niwa, Koji Iinuma, Masahiro Nakano, Masayuki Tomioka, Masaya Ito, Takayuki Mori, Kota Kawase, Tomoki Taniguchi, Yuki Tobisawa, Keita Nakane, Masayuki Matsuo, Takuya Koie

International Journal of Clinical Oncology · 2026-06 · 31 (6) · 1008-1016

DOI: 10.1007/s10147-026-03020-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 29.03.2026. Verfasst von Kojiro Niwa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Iodine Radioisotopes, Neoplasms, Second Primary. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gifu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low-dose-rate brachytherapy with iodine-125 (LDR-BT) is an established curative radiation treatment modality for localized prostate cancer (PCa). This study aimed to evaluate the long-term incidence of secondary primary tumors (SPTs) following LDR-BT in Japanese patients with localized PCa and identify predictive factors associated with SPTs. Methods and materials We retrospectively reviewed the clinical records of 478 consecutive patients with localized PCa who underwent LDR-BT at the Gifu University Hospital. This study’s primary endpoint was SPTs incidence, including bladder and rectal/anal cancers. The secondary endpoint was the identification of risk factors for LDR-BT that predicted SPTs development.

Results

After a median follow-up period of 105 months, SPTs developed in 13 patients (2.7%). Bladder cancer and rectal/anal canal cancer were observed in seven (1.5%) and six (1.3%) patients, respectively. Multivariate analysis showed that a biologically effective dose (BED) ≥ 197 Gy was associated with increased risk of SPTs (hazard ratio 4.145; 95% confidence interval 1.108–15.498; p = 0.035).

Conclusions

The incidence of SPTs following LDR-BT was relatively low. In multivariate analysis, BED ≥ 197 Gy may be associated with an increased risk of SPT occurrence. Adequate tumor control can be achieved through appropriate radiation dose administration; carefully planned long-term follow-up may be beneficial for SPTs early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyIodine RadioisotopesNeoplasms, Second PrimaryNeoplasms, Radiation-InducedHumansMaleAgedRetrospective StudiesMiddle AgedAged, 80 and overRadiotherapy DosageIncidenceRisk Factors

Stichwörter der Autor:innen

Biologically effective doseLate toxicityLow-dose-rate brachytherapyProstate cancerSecondary primary tumor

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan.
  • Department of Urology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan. iinuma.koji.s0@f.gifu-u.ac.jp.
  • Department of Urology, Gifu Prefectural General Medical Center, 4-6-1 Noisiki, Gifu, Gifu, 500-8717, Japan.
  • Department of Radiology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan.

Förderung

  • Gifu University

Zitieren

APA

Niwa, K., Iinuma, K., Nakano, M., Tomioka, M., Ito, M., Mori, T., Kawase, K., Taniguchi, T., Tobisawa, Y., Nakane, K., Matsuo, M., & Koie, T. (2026). Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer. International Journal of Clinical Oncology, 31(6), 1008-1016. https://doi.org/10.1007/s10147-026-03020-3

Vancouver

Niwa K, Iinuma K, Nakano M, Tomioka M, Ito M, Mori T, et al. Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer. International Journal of Clinical Oncology. 2026;31(6):1008-1016. doi:10.1007/s10147-026-03020-3

BibTeX
@article{Niwa2026,
  author = {Niwa, Kojiro and Iinuma, Koji and Nakano, Masahiro and Tomioka, Masayuki and Ito, Masaya and Mori, Takayuki and Kawase, Kota and Taniguchi, Tomoki and Tobisawa, Yuki and Nakane, Keita and Matsuo, Masayuki and Koie, Takuya},
  title = {Secondary primary tumors following iodine-125 low-dose-rate brachytherapy for localized prostate cancer},
  journal = {International Journal of Clinical Oncology},
  year = {2026},
  volume = {31},
  number = {6},
  pages = {1008--1016},
  doi = {10.1007/s10147-026-03020-3}
}
Kostenlos starten →